Cargando…
Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β-catenin
Glioblastoma multiforme (GBM) is the most common type of malignant brain tumor. GBM is currently treated with temozolomide (TMZ), although patients often exhibit resistance to this agent. Although several mechanisms underlying the resistance of GBM to TMZ have been identified, the combination of the...
Autores principales: | Sun, Datong, Yang, Shenghui, Zhang, Xufeng, Li, Sai, Wang, Lin, Chen, Junmin, Qiu, Chun, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933757/ https://www.ncbi.nlm.nih.gov/pubmed/33692860 http://dx.doi.org/10.3892/ol.2021.12580 |
Ejemplares similares
-
Forkhead box O1 targeting replication factor C subunit 2 expression promotes glioma temozolomide resistance and survival
por: Qiu, Xingsheng, et al.
Publicado: (2021) -
Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney Injury
por: Rao, Padmashree, et al.
Publicado: (2021) -
Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009) -
Hepcidin deficiency causes bone loss through interfering with the canonical Wnt/β-catenin pathway via Forkhead box O3a
por: Li, Guangfei, et al.
Publicado: (2020) -
The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus
por: Marchelek-Mysliwiec, Malgorzata, et al.
Publicado: (2022)